News & Events

BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today a new 10-city U.S. seminar series, BD Biosciences Technology Days, to provide life science researchers and industrial scientists comprehensive scientific information about technological advances in cell analysis to help speed the pace of biomedical research and discovery.

“Today’s researchers are under enormous pressure to demonstrate the value of their work and also to keep abreast of rapid changes in technology that could enhance their capability to answer complex biological and medical questions,” said Robert Balderas, Vice President, R&D, BD Biosciences. “BD’s Technology Days seminars will help the scientific community better understand the latest cell analysis technologies that have the potential to transform life science research.”

The BD seminar series, scheduled to run from February 27 through April 25, will offer information about new reagents and products in flow cytometry and bioimaging as well as discussions on how to apply them. Presentations by leading scientists from the research community and BD representatives will provide insights into cell signaling, multiplexing, phosphorylation and other topics. Researchers will report on their work using these advanced cell analysis technologies to find drug candidates or treatment regimens for specific diseases. In addition to the seminar presentations, BD will host a roundtable discussion for attendees to obtain answers to their scientific and technological questions.

Agendas, locations and registration information for the 2007 BD Biosciences Technology Days seminar series can be found at: www.bdbiosciences.com/technologydays.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 27,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.